Blog
RSS FeedPosted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...
Posted by Michael Wonder on 04 Mar 2021
The PHARMAC non-review?
4 March 2021 - The recently announced PHARMAC review is fatally flawed. ...
Posted by Michael Wonder on 03 Mar 2021
Cancer patient told palliative care only option after being rejected PHARMAC funding
2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...
Posted by Michael Wonder on 03 Mar 2021
PHARMAC ripe for reassessment
3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...
Posted by Michael Wonder on 02 Mar 2021
Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise
2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...
Posted by Michael Wonder on 01 Mar 2021
Review asks how Government can get the new drugs it wants funded
2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...
Posted by Michael Wonder on 01 Mar 2021
Proposal to fully fund Mercilon 28 for oral contraception
26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...
Posted by Michael Wonder on 28 Feb 2021
New Zealand Pharmaceutical Schedule - 1 March 2021
1 March 2021 - The March 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 25 Feb 2021
Multiple sclerosis treatments
25 February 2021 - From 1 March 2021, more people will be able to access multiple sclerosis treatments for longer. ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks - inquest
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...
Posted by Michael Wonder on 22 Feb 2021
Maker of epilepsy drug warned over quality control
23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 17 Feb 2021
Supplier of expensive cystic fibrosis medication yet to apply for PHARMAC approval
17 February 2021 - Government drug-buying agency PHARMAC has revealed the supplier of expensive cystic fibrosis medicine Trikafta still hasn’t ...